Dong Won Baek

460 total citations
52 papers, 285 citations indexed

About

Dong Won Baek is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Dong Won Baek has authored 52 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 21 papers in Hematology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Dong Won Baek's work include Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Dong Won Baek is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Dong Won Baek collaborates with scholars based in South Korea and Japan. Dong Won Baek's co-authors include Joon Ho Moon, Hee Jeong Cho, Jong Gwang Kim, Byung Woog Kang, Sang Kyun Sohn, Yu Kyung Kim, Jang Soo Suh, Gyu‐Seog Choi, Yee Soo Chae and Jun Seok Park and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Medicine.

In The Last Decade

Dong Won Baek

43 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dong Won Baek South Korea	10	126	63	58	57	49	52	285
Young Bae Choi South Korea	11	68 0.5×	28 0.4×	23 0.4×	97 1.7×	49 1.0×	36	313
George Yaghmour United States	12	163 1.3×	24 0.4×	59 1.0×	143 2.5×	16 0.3×	62	334
Man Fai Law China	8	65 0.5×	40 0.6×	42 0.7×	21 0.4×	24 0.5×	22	239
Senaka Peter United States	7	87 0.7×	25 0.4×	41 0.7×	104 1.8×	87 1.8×	17	308
Wei Shu Wang Taiwan	8	196 1.6×	20 0.3×	59 1.0×	32 0.6×	45 0.9×	12	338
Bachar Samra United States	9	136 1.1×	39 0.6×	39 0.7×	150 2.6×	13 0.3×	18	364
Antonella Romanelli Italy	7	127 1.0×	26 0.4×	132 2.3×	110 1.9×	24 0.5×	9	333
William Wu United States	9	173 1.4×	31 0.5×	86 1.5×	16 0.3×	36 0.7×	20	276
Olga Militano United States	12	176 1.4×	36 0.6×	65 1.1×	247 4.3×	25 0.5×	42	446
Fehmi Hindilerden Türkiye	9	54 0.4×	56 0.9×	29 0.5×	79 1.4×	23 0.5×	38	218

Countries citing papers authored by Dong Won Baek

Since Specialization

Citations

This map shows the geographic impact of Dong Won Baek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Won Baek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Won Baek more than expected).

Fields of papers citing papers by Dong Won Baek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Won Baek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Won Baek. The network helps show where Dong Won Baek may publish in the future.

Co-authorship network of co-authors of Dong Won Baek

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Won Baek. A scholar is included among the top collaborators of Dong Won Baek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Won Baek. Dong Won Baek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sohn, Sang Kyun, Young‐Eun Jang, Yunji Lee, et al.. (2024). Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents?. Expert Review of Hematology. 17(7). 353–359.

Koh, Young‐Il, Ja Min Byun, Junshik Hong, et al.. (2024). Glofitamab combined with poseltinib and lenalidomide for relapsed/refractory diffuse large B cell lymphoma: Interim analysis of GPL study.. Journal of Clinical Oncology. 42(16_suppl). 7066–7066. 2 indexed citations

Cho, Hee Jeong, et al.. (2024). Synergistic Effect of Venetoclax and Bendamustine in Early T-cell Precursor Acute Lymphoblastic Leukemia. In Vivo. 38(4). 1740–1749. 2 indexed citations

Lee, Dong Hyeon, Hee Jeong Cho, Sang Kyun Sohn, et al.. (2023). Circulating-tumor DNA Assessment in Diffuse Large B-cell Lymphoma to Determine Up-front Stem Cell Transplantation: A Pilot Study. In Vivo. 38(1). 372–379. 2 indexed citations

Baek, Dong Won, Han‐Seung Park, Sang Kyun Sohn, et al.. (2023). Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. The Korean Journal of Internal Medicine. 38(5). 734–746. 5 indexed citations

Cho, Hee Jeong, et al.. (2022). Clinical impact of spine magnetic resonance imaging as a valuable prognostic tool for patients with multiple myeloma: a retrospective study. SHILAP Revista de lepidopterología. 39(4). 300–308. 1 indexed citations

Hwang, Soyoon, et al.. (2022). Severe congenital neutropenia mimicking chronic idiopathic neutropenia: a case report. SHILAP Revista de lepidopterología. 40(3). 283–288.

Cho, Hee Jeong, Dong Won Baek, Ju-Hyung Kim, et al.. (2021). Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline. Clinical Lymphoma Myeloma & Leukemia. 22(2). 113–120. 1 indexed citations

Baek, Dong Won, Dae Young Kim, Sang Kyun Sohn, et al.. (2021). Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study. The Korean Journal of Internal Medicine. 36(6). 1471–1485. 3 indexed citations

10.

Kang, Byung Woog, Dong Won Baek, Hye Jin Kim, et al.. (2021). Clinical implication of adjuvant chemotherapy according to mismatch repair status in patients with intermediate-risk stage II colon cancer: a retrospective study. SHILAP Revista de lepidopterología. 39(2). 141–149. 2 indexed citations

11.

Baek, Dong Won, Ji Young Park, Soo Jung Lee, & Yee Soo Chae. (2020). The Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Relapsed Ectopic Male Breast Cancer. Journal of Breast Cancer. 23(5). 560–560.

12.

Song, Ga‐Young, Dok Hyun Yoon, Cheolwon Suh, et al.. (2020). Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma. Bone Marrow Transplantation. 56(5). 1205–1208. 10 indexed citations

13.

Baek, Dong Won, et al.. (2020). Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma. Blood Research. 55(2). 99–106. 11 indexed citations

14.

Baek, Jin Ho, Dong Won Baek, Byung Woog Kang, et al.. (2020). Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy. In Vivo. 34(4). 1993–1999. 10 indexed citations

15.

Baek, Dong Won, Hee Jeong Cho, Ju-Hyung Kim, et al.. (2020). Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma. In Vivo. 34(4). 2127–2134. 4 indexed citations

16.

Baek, Dong Won, Soo Jung Lee, Sang Kyun Sohn, Joon Ho Moon, & Yee Soo Chae. (2019). Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer. Journal of Breast Cancer. 22(4). 647–647. 1 indexed citations

17.

Park, Sungwoo, Dong Won Baek, Sang Kyun Sohn, et al.. (2019). Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 19(7). e367–e373. 2 indexed citations

18.

Baek, Dong Won, Ju‐Hyung Kim, Hee Jeong Cho, et al.. (2019). Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3 -ITD. Blood Research. 54(3). 189–197. 1 indexed citations

19.

Cho, Hee Jeong, Dong Won Baek, Sungwoo Park, et al.. (2018). Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen. SHILAP Revista de lepidopterología. 35(1). 76–83. 3 indexed citations

20.

Lee, Yoo Jin, Dong Won Baek, Jae‐Sook Ahn, et al.. (2018). Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission. Clinical Lymphoma Myeloma & Leukemia. 18(12). e529–e535. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact